MicroPort CardioFlow Medtech Corporation (72X.F)
- Previous Close
0.0830 - Open
0.0815 - Bid 0.0880 x --
- Ask 0.0995 x --
- Day's Range
0.0815 - 0.0815 - 52 Week Range
0.0290 - 0.1350 - Volume
792 - Avg. Volume
22 - Market Cap (intraday)
221.911M - Beta (5Y Monthly) 0.56
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Mar 27, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People's Republic of China and internationally. It engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valvular heart diseases, as well as properties management. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set, Angelguide tip-preshaped super stiff guidewire, mitral, tricuspid, and surgical accessories, as well as procedural accessories. The company also provides technical consultation and technical services for medical devices clinical trial. MicroPort CardioFlow Medtech Corporation was founded in 2009 and is headquartered in Shanghai, China.
www.cardioflowmedtech.comRecent News: 72X.F
View MorePerformance Overview: 72X.F
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 72X.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 72X.F
View MoreValuation Measures
Market Cap
226.00M
Enterprise Value
66.96M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.33
Price/Book (mrq)
0.73
Enterprise Value/Revenue
1.49
Enterprise Value/EBITDA
12.03
Financial Highlights
Profitability and Income Statement
Profit Margin
-13.68%
Return on Assets (ttm)
-3.28%
Return on Equity (ttm)
-2.34%
Revenue (ttm)
361.56M
Net Income Avi to Common (ttm)
-49.45M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
1.36B
Total Debt/Equity (mrq)
3.46%
Levered Free Cash Flow (ttm)
8.6M